Browsing by Author Gascón, Pere
Showing results 16 to 33 of 33
< previous
| Issue Date | Title | Author(s) |
|---|---|---|
| 30-Jun-2016 | Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung | Lugo, Roberto; Gabasa Ferràndez, Marta; Andriani, Francesca; Puig, Marta; Facchinetti, Federica; Ramírez Ruz, J. (José); Gómez Caro, Abel; Pastorino, Ugo; Fuster Orellana, Gemma; Almendros López, Isaac; Gascón, Pere; Dávalos, Albert; Reguart, Noemí; Roz, Luca; Alcaraz Casademunt, Jordi |
| 28-Jun-2018 | Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer | Fernández-Nogueira, Patricia; Noguera Castells, Aleix; Fuster Orellana, Gemma; Recalde Percaz, Leire; Moragas, Núria; López Plana, Anna; Enreig, Estel; Jauregui, Patricia; Carbó Carbó, Neus; Almendro Navarro, Vanessa; Gascón, Pere; Bragado, Paloma; Mancino, Mario |
| 15-Sep-2015 | Hypoxia drives breast malignancy through a TET -TNFα-p38-MAPK signaling axis. | Wu, Min-Zu; Chen, Su-Feng; Nieh, Shin; Benner, Christopher; Ger, Luo-Ping; Jan, Chia-Ing; Ma, Li; Chen, Chien-Hung; Hishida, Tomoaki; Chang, Hong-Tai; Lin, Yaoh-Shiang; Montserrat Pulido, Núria; Gascón, Pere; Sancho-Martinez, Ignacio; Izpisúa Belmonte, Juan Carlos |
| 23-Jan-2014 | Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity. | Almendro Navarro, Vanessa; Cheng, Yu-Kan; Randles, Amanda; Itzkovitz, Shalev; Marusyk, Andriy; Ametller, Elisabet; Gonzalez-Farre, Xavier; Muñoz Mateu, Montserrat; Russnes, Hage G.; Helland, Åslaug; Rye, Inga H.; Borresen-Dale, Anne-Lise; Maruyama, Reo; Oudenaarden, Alexander van; Dowsett, Mitchell; Jones, Robin L.; Reis-Filho, Jorge; Gascón, Pere; Gönen, Mithat; Michor, Franziska; Polyak, Kornelia |
| 18-Dec-2015 | Influence of stress and microenvironmental factors in the progression from breast ductal carcinoma in situ to invasiveness | Zubeldia Plazaola, Arantzazu |
| 14-Sep-2012 | Malaltia tromboembòlica venosa en el pacient oncològic: noves formes de presentació clínica i paper dels anticossos antifosfolípid en la seva patogènia | Font i Puig, Carme |
| 6-Mar-2021 | MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence | Gabasa Ferràndez, Marta; Radisky, Evette S; Ikemori, Rafael; Bertolini, Giulia; Arshakyan, Marselina; Hockla, Alexandra; Duch, Paula; Rondinone, Ornella; Llorente, Alejandro; Maqueda, Maria; Dávalos, Albert; Gavilán, Elena; Perera Lluna, Alexandre; Ramírez, Josep; Gascón, Pere; Reguart, Noemí; Roz, Luca; Radisky, Derek C; Alcaraz Casademunt, Jordi |
| 12-Mar-2015 | Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer. | Marín Aguilera, Mercedes; Reig Torras, Oscar; Lozano Salvatella, Juan José; Jiménez, Natalia; Garcia Recio, Susana; Erill, Nadina; Gaba, Lydia; Tagliapietra, Andrea; Ortega, Vanessa; Carrera, Gemma; Colomer, Anna; Gascón, Pere; Mellado González, Begoña |
| 30-Jun-2021 | Neuropilin 2 role in the regulation of disseminated tumour cells dormancy and metastasis in breast and head and neck cancer | Recalde-Percaz, Leire |
| 26-Feb-2021 | Paper dels factors neuronals SEMA3F i NTN1 en la transició de càncer de mama in situ a invasiu | Moragas Garcia, Núria |
| 17-Sep-2021 | Prevalence of silent breast cancer in autopsy specimens: study of the diseases held by image-guided biopsies | Sidiropoulou, Zacharoula |
| 24-Jul-2007 | sFAS/sFASL and sMMP-7: New soluble markers of prognosis and response to therapy in advanced colorectal cancer | Nadal Sanmartin, Cristina |
| Nov-2013 | Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. | Garcia Recio, Susana; Fuster Orellana, Gemma; Fernandez-Nogueira, Patricia; Pastor Arroyo, Eva M.; Yeong Park, So; Mayordomo, Cristina; Ametller, Elisabet; Mancino, Mario; Gonzalez-Farre, Xavier; Russnes, Hage G.; Engel Rocamora, Pablo; Costamagna, Domiziana; Fernandez, Pedro L.; Gascón, Pere; Almendro Navarro, Vanessa |
| 12-May-2016 | The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase | Erazo, Tatiana; Lorente, Mar; López Plana, Anna; Muñoz Guardiola, Pau; Fernandez-Nogueira, Patricia; García-Martinez, José A.; Bragado, Paloma; Fuster Orellana, Gemma; Salazar, María; Espadaler, Jordi; Hernández Losa, Javier; Bayascas, Jose R.; Cortal, Marc; Vidal, Laura; Gascón, Pere; Gómez Ferreria, Mariana; Alfón, José; Velasco, Guillermo; Domènech, Carles; Lizcano, José Miguel |
| 6-Mar-2009 | The Role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin | Almendro Navarro, Vanessa; Ametller, Elisabet; Garcia Recio, Susana; Collazo, Olga; Casas, Ignasi; Augé Fradera, Josep Maria; Maurel Santasusana, Joan; Gascón, Pere |
| 26-Jun-2015 | The transmodulation of HER2 and EGFR by Substance P in breast cancer cells requires c-Src and metalloproteinase activation. | Garcia Recio, Susana; Pastor Arroyo, Eva M.; Marín Aguilera, Mercedes; Almendro Navarro, Vanessa; Gascón, Pere |
| 2010 | Tumor promoting effects of CD95 signalling in chemoresistant cells | Ametller, Elisabet; Garcia-Recio, Susana; Costamagna, Domiziana; Mayordomo, Cristina; Fernandez-Nogueira, Patricia; Carbó Carbó, Neus; Pastor Arroyo, Eva M.; Gascón, Pere; Almendro Navarro, Vanessa |
| 8-Dec-2020 | Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression | Bragado, Paloma; Fernández-Nogueira, Patricia; Carbó Carbó, Neus; Gascón, Pere |